 |  |
November 21, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E., Mail Stop 3561
Washington, D.C. 20549
| Attn: | Chris Edwards |
| Re: | Sonoma Pharmaceuticals, Inc. |
| Registration Statement on Form S-3, as amended Filed November 9, 2017, and amended on November 17, 2017 File No. 333-221477 | |
| Acceleration Request | |
| Requested Date: November 27, 2017 | |
| Requested Time: 4:00 P.M. EST | |
Dear Mr. Edwards:
Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests that the above-captioned Registration Statement on Form S-3 (the “Registration Statement”) be accelerated to Monday, November 27, 2017 at 4:00 p.m. EST or as soon as practicable thereafter.
The cooperation of the staff in meeting our request is very much appreciated. Please call Amy Trombly at (617) 243-0060 if you have any questions or if we can otherwise be of assistance to you.
Very truly yours,
/s/ Jim Schutz
By: Jim Schutz
Chief Executive Officer
cc: Amy Trombly, Esq.